Apremilast for Alcohol Use Disorder Treatment in Women and Men

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 8, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions

Alcohol Use Disorder

Interventions

DRUG

Apremilast

60mg/day

Trial Locations (1)

Yale University, New Haven

All Listed Sponsors

collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

collaborator

Office of Research on Women's Health (ORWH)

NIH

lead

Yale University

OTHER

NCT06324435 - Apremilast for Alcohol Use Disorder Treatment in Women and Men | Biotech Hunter | Biotech Hunter